Home > Qtrly Results > AJANTA PHARMA

AJANTA PHARMA
Quarterly Results Analysis [Mar2025]

AJANTA PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
COMMUNITY POLL
for AJANTA PHARMA
Please provide your vote to see the results

AJANTA PHARMA Quarterly Results

Consolidated Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Revenues ₹1,170 Cr ₹1,146 Cr ₹1,187 Cr ₹1,145 Cr ₹1,054 Cr ₹1,105 Cr ₹1,028 Cr ₹1,021 Cr
Expenses ₹873 Cr ₹825 Cr ₹875 Cr ₹815 Cr ₹776 Cr ₹791 Cr ₹738 Cr ₹750 Cr
Operating Income ₹297 Cr ₹321 Cr ₹311 Cr ₹330 Cr ₹278 Cr ₹314 Cr ₹291 Cr ₹271 Cr
Other Income ₹18 Cr ₹30 Cr ₹19 Cr ₹26 Cr ₹36 Cr ₹14 Cr ₹21 Cr ₹32 Cr
Interest ₹6 Cr ₹8 Cr ₹6 Cr ₹1 Cr ₹2 Cr ₹2 Cr ₹2 Cr ₹1 Cr
Depreciation ₹40 Cr ₹36 Cr ₹34 Cr ₹34 Cr ₹34 Cr ₹34 Cr ₹34 Cr ₹33 Cr
Profit Before Tax ₹269 Cr ₹307 Cr ₹290 Cr ₹322 Cr ₹278 Cr ₹291 Cr ₹276 Cr ₹269 Cr
Profit After Tax ₹225 Cr ₹233 Cr ₹216 Cr ₹246 Cr ₹203 Cr ₹210 Cr ₹195 Cr ₹208 Cr
EPS ₹17.97 ₹18.58 ₹17.27 ₹19.61 ₹16.04 ₹16.62 ₹15.46 ₹16.47
Industry Peers & Returns1W1M1Y
AJANTA PHARMA 4.1% 1.6% 13%
SUN PHARMACEUTICAL INDUSTRIES -0.6% 0.8% 10.5%
DIVIS LABORATORIES 3.1% 3.8% 49.2%
CIPLA 0.4% 2.5% 1.2%
TORRENT PHARMACEUTICALS -0.2% 6.4% 20.5%
DR REDDYS LABORATORIES -0.6% 3.3% 0.1%
MANKIND PHARMA 1.3% 0.7% 10.4%
ZYDUS LIFESCIENCES 1.8% 7.3% -6.7%
LUPIN 1% 0.7% 21.7%

AJANTA PHARMA Quarterly Revenues

Revenues
Q-o-Q

2.12 %

Y-o-Y

11.04 %

Quarters Revenues % Change
Mar2025 ₹1,170 Cr
2.12
Dec2024 ₹1,146 Cr
-3.41
Sep2024 ₹1,187 Cr
3.64
Jun2024 ₹1,145 Cr
8.62
Mar2024 ₹1,054 Cr
-4.62
Dec2023 ₹1,105 Cr
7.46
Sep2023 ₹1,028 Cr
0.72
Jun2023 ₹1,021 Cr -

AJANTA PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

-7.38 %

Y-o-Y

6.77 %

Quarters Operating Profit % Change
Mar2025 ₹297 Cr
-7.38
Dec2024 ₹321 Cr
3.10
Sep2024 ₹311 Cr
-5.81
Jun2024 ₹330 Cr
18.69
Mar2024 ₹278 Cr
-11.38
Dec2023 ₹314 Cr
8.05
Sep2023 ₹291 Cr
7.13
Jun2023 ₹271 Cr -
Operating Margins
Q-o-Q

-9.29 %

Y-o-Y

-3.83 %

Quarters Operating Margin% % Change
Mar2025 25.39%
-9.29
Dec2024 27.99%
6.75
Sep2024 26.22%
-9.12
Jun2024 28.85%
9.28
Mar2024 26.4%
-7.11
Dec2023 28.42%
0.57
Sep2023 28.26%
6.36
Jun2023 26.57% -

AJANTA PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-3.27 %

Y-o-Y

11.12 %

Quarters Profit After Tax % Change
Mar2025 ₹225 Cr
-3.27
Dec2024 ₹233 Cr
7.58
Sep2024 ₹216 Cr
-11.92
Jun2024 ₹246 Cr
21.24
Mar2024 ₹203 Cr
-3.48
Dec2023 ₹210 Cr
7.54
Sep2023 ₹195 Cr
-6.16
Jun2023 ₹208 Cr -
PAT Margins
Q-o-Q

-5.27 %

Y-o-Y

0.10 %

Quarters PAT Margin(%) % Change
Mar2025 19.25 %
-5.27
Dec2024 20.32 %
11.40
Sep2024 18.24 %
-15.04
Jun2024 21.47 %
11.65
Mar2024 19.23 %
1.21
Dec2023 19 %
0.05
Sep2023 18.99 %
-6.82
Jun2023 20.38 % -

AJANTA PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-3.28 %

Y-o-Y

12.03 %

Quarters EPS % Change
Mar2025 ₹17.97
-3.28
Dec2024 ₹18.58
7.59
Sep2024 ₹17.27
-11.93
Jun2024 ₹19.61
22.26
Mar2024 ₹16.04
-3.49
Dec2023 ₹16.62
7.50
Sep2023 ₹15.46
-6.13
Jun2023 ₹16.47 -

You may also like the below Video Courses